National Bank of Canada FI Grows Stock Holdings in CVS Health Corporation $CVS

National Bank of Canada FI increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 50.3% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,770,840 shares of the pharmacy operator’s stock after purchasing an additional 593,015 shares during the period. National Bank of Canada FI’s holdings in CVS Health were worth $133,495,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. National Pension Service lifted its holdings in shares of CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC grew its stake in CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock worth $7,873,000 after buying an additional 79,340 shares during the last quarter. AE Wealth Management LLC increased its position in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after buying an additional 14,983 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock valued at $16,971,000 after buying an additional 22,653 shares during the last quarter. Finally, Alpha Omega Wealth Management LLC boosted its holdings in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.4%

CVS Health stock opened at $75.81 on Tuesday. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The stock has a market capitalization of $96.45 billion, a PE ratio of 54.94, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49. The firm has a 50 day simple moving average of $78.08 and a 200-day simple moving average of $77.85. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the prior year, the firm posted $1.19 earnings per share. The firm’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

Analyst Ratings Changes

CVS has been the subject of several research reports. Sanford C. Bernstein upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and upped their price target for the company from $91.00 to $94.00 in a research report on Thursday, March 12th. Piper Sandler restated an “overweight” rating and issued a $101.00 price objective (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. TD Cowen reissued a “buy” rating on shares of CVS Health in a report on Friday. Finally, The Goldman Sachs Group boosted their price target on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.